Table 1 Selected patient and tumor characteristics
From: Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
| N = 65 | ||
|---|---|---|
| Age (years) | Median (range) | |
| Median | 59 (22-74) | |
| N (%) | ||
| < 50 | 15 (23) | |
| ≥ 50 | 50 (77) | |
| Sex | ||
| Male | 37 (57) | |
| Female | 28 (43) | |
| PS | ||
| 0 | 34 (52) | |
| 1 | 25 (38) | |
| 2 | 6 (9) | |
| Surgery | ||
| Partial/Biopsy* | 19 (29) | |
| Sutotal resection | 33 (51) | |
| Total resection | 13 (20) | |
| Hemisphere | ||
| Left | 33 (51) | |
| Right | 29 (45) | |
| Bilateral | 3 (5) | |
| Location | ||
| Temporal | 20 (31) | |
| Parietal | 20 (31) | |
| Occipital | 3 (5) | |
| Frontal | 17 (26) | |
| Deep | 8 (12) | |
| Volumetric parameters | Median (range) | |
| Enhancing tumor (cm3) | 34.7 (2.3-117.5) | |
| Preoperative | T2 abnormality (cm3) | 108.1 (3.8-230.9) |
| Necrosis (cm3) | 5.8 (0-57) | |
| PreRCT | Net-enhancing tumor (cm3) | 11 (0-80.8) |
